Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Allogene Therapeutics Inc Share Price

ALLO

NSQ

$1.8

+$0.18

(11.11%)

Industry: Biotechnology Sector: Health Care

Allogene Therapeutics Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

Allogene Therapeutics Inc Share Price Chart

Allogene Therapeutics Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$364.06M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

4.71M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.60

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$0.86 L

$3.78 H

$1.8

About Allogene Therapeutics Inc, Common Stock

Allogene Therapeutics, Inc. a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases. It develops, manufactures, and commercializes UCART19, an allogeneic anti-CD19 chimeric antigen receptor (CAR) T cell product candidate for the treatment of patients with R/R CD19 positive B-cell acute lymphoblastic leukemia (ALL). The company also develops cemacabtagene ansegedleucel, an engineered allogeneic CAR T cell product candidate that targets CD19 for the treatment of large B-cell lymphoma. In addition, it provides clinical-stage products, such as ALLO-501, cema-cel, ALLO-316, ALLO-329, ALLO-715, and ALLO-605; DLL3 for the treatment of small cell lung cancer; Claudin 18.2 for the treatment of gastric and pancreatic cancer; and FLT3 for the treatment of acute myeloid leukemia. The company has license and collaboration agreements with Pfizer Inc., Servier, Cellectis S.A., and Notch Therapeutics Inc. It also has a strategic collaboration agreement with The University of Texas MD Anderson Cancer Center for the preclinical and clinical investigation of allogeneic CAR T cell product candidates; and a strategic partnership with Foresight Diagnostics to develop MRD-based In-Vitro Diagnostic for use in ALPHA3. The company was incorporated in 2017 and is headquartered in South San Francisco, California. more

Industry: BiotechnologySector: Health Care

Allogene Therapeutics Inc Stock Returns

Time Frame	ALLO	Sector	S&P500
1-Week Return	-4.14%	-1.08%	-1.38%
1-Month Return	-1.22%	-0.47%	-1.81%
3-Month Return	35%	2.13%	1.38%
6-Month Return	55.77%	17.04%	5.68%
1-Year Return	14.89%	6.56%	11.74%
3-Year Return	-77.25%	16.78%	65.15%
5-Year Return	-95.14%	34.34%	73.68%
10-Year Return	-93.52%	137.88%	260.03%

Time Frame	ALLO	Sector	S&P500
1-Week Return	-88.97%	-43.23%	-51.55%
1-Month Return	-13.87%	-5.57%	-19.93%
3-Month Return	237.73%	8.92%	5.72%
6-Month Return	145.65%	37.58%	11.85%
1-Year Return	14.89%	6.56%	11.74%
3-Year Return	-38.95%	5.31%	18.20%
5-Year Return	-45.38%	6.08%	11.67%
10-Year Return	-23.94%	9.05%	13.67%

Allogene Therapeutics Inc Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	38.34M	38.49M	243.00K	95.00K	22.00K	[{"date":"2020-12-31","value":99.63,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":0.63,"profit":true},{"date":"2023-12-31","value":0.25,"profit":true},{"date":"2024-12-31","value":0.06,"profit":true}]
Cost of Revenue	11.54M	13.06M	16.73M	14.20M	13.64M	[{"date":"2020-12-31","value":68.99,"profit":true},{"date":"2021-12-31","value":78.1,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":84.88,"profit":true},{"date":"2024-12-31","value":81.53,"profit":true}]
Gross Profit	(11.54M)	38.49M	243.00K	95.00K	22.00K	[{"date":"2020-12-31","value":-29.99,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":0.63,"profit":true},{"date":"2023-12-31","value":0.25,"profit":true},{"date":"2024-12-31","value":0.06,"profit":true}]
Gross Margin	(30.10%)	100.00%	100.00%	100.00%	100.00%	[{"date":"2020-12-31","value":-30.1,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Operating Expenses	258.24M	294.28M	335.69M	327.83M	273.22M	[{"date":"2020-12-31","value":76.93,"profit":true},{"date":"2021-12-31","value":87.66,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":97.66,"profit":true},{"date":"2024-12-31","value":81.39,"profit":true}]
Operating Income	(258.24M)	(255.79M)	(335.45M)	(327.74M)	(273.20M)	[{"date":"2020-12-31","value":-25824300000,"profit":false},{"date":"2021-12-31","value":-25579200000,"profit":false},{"date":"2022-12-31","value":-33544900000,"profit":false},{"date":"2023-12-31","value":-32773700000,"profit":false},{"date":"2024-12-31","value":-27319900000,"profit":false}]
Total Non-Operating Income/Expense	17.19M	501.00K	7.38M	15.27M	36.02M	[{"date":"2020-12-31","value":47.71,"profit":true},{"date":"2021-12-31","value":1.39,"profit":true},{"date":"2022-12-31","value":20.49,"profit":true},{"date":"2023-12-31","value":42.39,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income	(250.22M)	(257.00M)	(332.63M)	(327.26M)	(257.15M)	[{"date":"2020-12-31","value":-25022100000,"profit":false},{"date":"2021-12-31","value":-25700500000,"profit":false},{"date":"2022-12-31","value":-33263200000,"profit":false},{"date":"2023-12-31","value":-32726500000,"profit":false},{"date":"2024-12-31","value":-25714700000,"profit":false}]
Income Taxes	(16.75M)	(12.17M)	(2.82M)	(2.82M)	443.00K	[{"date":"2020-12-31","value":-3781.04,"profit":false},{"date":"2021-12-31","value":-2746.73,"profit":false},{"date":"2022-12-31","value":-635.89,"profit":false},{"date":"2023-12-31","value":-635.89,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes	(233.47M)	(244.84M)	(329.81M)	(324.45M)	(257.59M)	[{"date":"2020-12-31","value":-23347100000,"profit":false},{"date":"2021-12-31","value":-24483700000,"profit":false},{"date":"2022-12-31","value":-32981500000,"profit":false},{"date":"2023-12-31","value":-32444800000,"profit":false},{"date":"2024-12-31","value":-25759000000,"profit":false}]

Income From Continuous Operations	(250.22M)	(257.00M)	(332.63M)	(332.86M)	(257.59M)	[{"date":"2020-12-31","value":-25022100000,"profit":false},{"date":"2021-12-31","value":-25700500000,"profit":false},{"date":"2022-12-31","value":-33263200000,"profit":false},{"date":"2023-12-31","value":-33285500000,"profit":false},{"date":"2024-12-31","value":-25759000000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(233.47M)	(244.84M)	(329.81M)	(327.26M)	(257.59M)	[{"date":"2020-12-31","value":-23347100000,"profit":false},{"date":"2021-12-31","value":-24483700000,"profit":false},{"date":"2022-12-31","value":-32981500000,"profit":false},{"date":"2023-12-31","value":-32726500000,"profit":false},{"date":"2024-12-31","value":-25759000000,"profit":false}]

EPS (Diluted)	(2.08)	(1.89)	(2.32)	(2.01)	(1.33)	[{"date":"2020-12-31","value":-208,"profit":false},{"date":"2021-12-31","value":-189,"profit":false},{"date":"2022-12-31","value":-232,"profit":false},{"date":"2023-12-31","value":-201,"profit":false},{"date":"2024-12-31","value":-133,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	0.38%	(99.37%)	(60.91%)	(76.84%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-26460.35,"profit":false},{"date":"2023-12-31","value":-16218.16,"profit":false},{"date":"2024-12-31","value":-20461.88,"profit":false}]
Cost of Revenue	-	13.21%	28.04%	(15.12%)	(3.94%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":47.1,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-53.92,"profit":false},{"date":"2024-12-31","value":-14.07,"profit":false}]
Gross Profit	-	(433.50%)	(99.37%)	(60.91%)	(76.84%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Gross Margin	-	(432.25%)	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	-	13.96%	14.07%	(2.34%)	(16.66%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":99.17,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-16.64,"profit":false},{"date":"2024-12-31","value":-118.38,"profit":false}]
Operating Income	-	(0.95%)	31.14%	(2.30%)	(16.64%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-3.05,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-7.38,"profit":false},{"date":"2024-12-31","value":-53.44,"profit":false}]
Total Non-Operating Income/Expense	-	(97.08%)	1373.65%	106.84%	135.90%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-7.07,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":7.78,"profit":true},{"date":"2024-12-31","value":9.89,"profit":true}]
Pre-Tax Income	-	2.71%	29.43%	(1.61%)	(21.43%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":9.21,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-5.48,"profit":false},{"date":"2024-12-31","value":-72.81,"profit":false}]
Income Taxes	-	(27.36%)	(76.85%)	-	(115.73%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]
Income After Taxes	-	4.87%	34.71%	(1.63%)	(20.61%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":14.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-4.69,"profit":false},{"date":"2024-12-31","value":-59.37,"profit":false}]

Income From Continuous Operations	-	2.71%	29.43%	0.07%	(22.61%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":9.21,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":0.23,"profit":true},{"date":"2024-12-31","value":-76.84,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	4.87%	34.71%	(0.77%)	(21.29%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":14.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2.23,"profit":false},{"date":"2024-12-31","value":-61.34,"profit":false}]

EPS (Diluted)	-	(9.13%)	22.75%	(13.36%)	(33.83%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-40.15,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-58.73,"profit":false},{"date":"2024-12-31","value":-148.7,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	(22.00K)	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Cost of Revenue	3.21M	3.23M	3.10M	3.11M	31.16M	[{"date":"2024-09-30","value":10.29,"profit":true},{"date":"2024-12-31","value":10.37,"profit":true},{"date":"2025-03-31","value":9.94,"profit":true},{"date":"2025-06-30","value":9.97,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Profit	(3.21M)	(3.23M)	(3.10M)	(3.11M)	(31.16M)	[{"date":"2024-09-30","value":-320700000,"profit":false},{"date":"2024-12-31","value":-323300000,"profit":false},{"date":"2025-03-31","value":-309900000,"profit":false},{"date":"2025-06-30","value":-310600000,"profit":false},{"date":"2025-09-30","value":-3116400000,"profit":false}]
Gross Margin	-	14695.45%	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	71.77M	57.26M	62.09M	56.82M	13.74M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":79.77,"profit":true},{"date":"2025-03-31","value":86.51,"profit":true},{"date":"2025-06-30","value":79.16,"profit":true},{"date":"2025-09-30","value":19.14,"profit":true}]
Operating Income	(71.77M)	(60.49M)	(65.19M)	(56.82M)	(44.90M)	[{"date":"2024-09-30","value":-7177400000,"profit":false},{"date":"2024-12-31","value":-6049000000,"profit":false},{"date":"2025-03-31","value":-6519100000,"profit":false},{"date":"2025-06-30","value":-5681900000,"profit":false},{"date":"2025-09-30","value":-4490100000,"profit":false}]
Total Non-Operating Income/Expense	12.09M	3.94M	10.82M	11.79M	7.08M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":32.6,"profit":true},{"date":"2025-03-31","value":89.56,"profit":true},{"date":"2025-06-30","value":97.59,"profit":true},{"date":"2025-09-30","value":58.6,"profit":true}]
Pre-Tax Income	(66.29M)	(59.50M)	(59.73M)	(50.94M)	(41.40M)	[{"date":"2024-09-30","value":-6629300000,"profit":false},{"date":"2024-12-31","value":-5949600000,"profit":false},{"date":"2025-03-31","value":-5973300000,"profit":false},{"date":"2025-06-30","value":-5094300000,"profit":false},{"date":"2025-09-30","value":-4140000000,"profit":false}]
Income Taxes	-	443.00K	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	(59.94M)	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-5993900000,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	(66.29M)	(59.94M)	(59.73M)	(50.94M)	(41.40M)	[{"date":"2024-09-30","value":-6629300000,"profit":false},{"date":"2024-12-31","value":-5993900000,"profit":false},{"date":"2025-03-31","value":-5973300000,"profit":false},{"date":"2025-06-30","value":-5094300000,"profit":false},{"date":"2025-09-30","value":-4140000000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(66.29M)	(59.94M)	(59.73M)	(50.94M)	(41.40M)	[{"date":"2024-09-30","value":-6629300000,"profit":false},{"date":"2024-12-31","value":-5993900000,"profit":false},{"date":"2025-03-31","value":-5973300000,"profit":false},{"date":"2025-06-30","value":-5094300000,"profit":false},{"date":"2025-09-30","value":-4140000000,"profit":false}]

EPS (Diluted)	(0.32)	(0.28)	(0.28)	(0.23)	(0.19)	[{"date":"2024-09-30","value":-32,"profit":false},{"date":"2024-12-31","value":-28,"profit":false},{"date":"2025-03-31","value":-28,"profit":false},{"date":"2025-06-30","value":-23,"profit":false},{"date":"2025-09-30","value":-19,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Cost of Revenue	-	0.81%	(4.14%)	0.23%	903.35%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":0.09,"profit":true},{"date":"2025-03-31","value":-0.46,"profit":false},{"date":"2025-06-30","value":0.03,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Profit	-	0.81%	(4.14%)	0.23%	903.35%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":0.09,"profit":true},{"date":"2025-03-31","value":-0.46,"profit":false},{"date":"2025-06-30","value":0.03,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Margin	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	-	(20.23%)	8.44%	(8.49%)	(75.82%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-239.52,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-100.57,"profit":false},{"date":"2025-09-30","value":-897.91,"profit":false}]
Operating Income	-	(15.72%)	7.77%	(12.84%)	(20.98%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-202.3,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-165.25,"profit":false},{"date":"2025-09-30","value":-269.9,"profit":false}]
Total Non-Operating Income/Expense	-	(67.40%)	174.72%	8.97%	(39.95%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-38.58,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":5.13,"profit":true},{"date":"2025-09-30","value":-22.86,"profit":false}]
Pre-Tax Income	-	(10.25%)	0.40%	(14.72%)	(18.73%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-2573.88,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-3694.15,"profit":false},{"date":"2025-09-30","value":-4702.62,"profit":false}]
Income Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	-	(9.58%)	(0.34%)	(14.72%)	(18.73%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	(9.58%)	(0.34%)	(14.72%)	(18.73%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

EPS (Diluted)	-	(12.50%)	-	(17.86%)	(17.39%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	845.13M	471.32M	528.82M	459.12M	303.39M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":55.77,"profit":true},{"date":"2022-12-31","value":62.57,"profit":true},{"date":"2023-12-31","value":54.32,"profit":true},{"date":"2024-12-31","value":35.9,"profit":true}]
Non-current Assets	382.70M	579.50M	292.75M	183.72M	245.32M	[{"date":"2020-12-31","value":66.04,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":50.52,"profit":true},{"date":"2023-12-31","value":31.7,"profit":true},{"date":"2024-12-31","value":42.33,"profit":true}]
Total Assets	1.23B	1.05B	821.58M	642.84M	548.71M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":85.58,"profit":true},{"date":"2022-12-31","value":66.91,"profit":true},{"date":"2023-12-31","value":52.36,"profit":true},{"date":"2024-12-31","value":44.69,"profit":true}]

Total Liabilities
Current Liabilities	94.32M	47.91M	53.73M	37.08M	35.52M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":50.79,"profit":true},{"date":"2022-12-31","value":56.96,"profit":true},{"date":"2023-12-31","value":39.31,"profit":true},{"date":"2024-12-31","value":37.66,"profit":true}]
Non-current Liabilities	53.89M	77.72M	100.97M	93.53M	91.01M	[{"date":"2020-12-31","value":53.37,"profit":true},{"date":"2021-12-31","value":76.98,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.63,"profit":true},{"date":"2024-12-31","value":90.13,"profit":true}]
Total Liabilities	148.21M	125.63M	154.70M	130.60M	126.53M	[{"date":"2020-12-31","value":95.81,"profit":true},{"date":"2021-12-31","value":81.21,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":84.43,"profit":true},{"date":"2024-12-31","value":81.79,"profit":true}]

Total Shareholders' equity
Common Stock	140.00K	142.00K	144.00K	169.00K	212.00K	[{"date":"2020-12-31","value":66.04,"profit":true},{"date":"2021-12-31","value":66.98,"profit":true},{"date":"2022-12-31","value":67.92,"profit":true},{"date":"2023-12-31","value":79.72,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(646.34M)	(894.55M)	(1.23B)	(1.56B)	(1.82B)	[{"date":"2020-12-31","value":-64634300000,"profit":false},{"date":"2021-12-31","value":-89455400000,"profit":false},{"date":"2022-12-31","value":-123496800000,"profit":false},{"date":"2023-12-31","value":-156223300000,"profit":false},{"date":"2024-12-31","value":-181982300000,"profit":false}]
Other Stockholders' Equity	1.73B	1.82B	1.91B	2.08B	2.24B	[{"date":"2020-12-31","value":76.97,"profit":true},{"date":"2021-12-31","value":81.28,"profit":true},{"date":"2022-12-31","value":85.27,"profit":true},{"date":"2023-12-31","value":92.57,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	1.08B	925.20M	666.88M	512.23M	422.18M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":85.7,"profit":true},{"date":"2022-12-31","value":61.77,"profit":true},{"date":"2023-12-31","value":47.45,"profit":true},{"date":"2024-12-31","value":39.1,"profit":true}]

Total Liabilities & Shareholders Equity	1.23B	1.05B	821.58M	642.84M	548.71M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":85.58,"profit":true},{"date":"2022-12-31","value":66.91,"profit":true},{"date":"2023-12-31","value":52.36,"profit":true},{"date":"2024-12-31","value":44.69,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	(44.23%)	12.20%	(13.18%)	(33.92%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-362.55,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-108.05,"profit":false},{"date":"2024-12-31","value":-278.03,"profit":false}]
Non-current Assets	-	51.43%	(49.48%)	(37.24%)	33.53%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-96.22,"profit":false},{"date":"2023-12-31","value":-72.42,"profit":false},{"date":"2024-12-31","value":65.2,"profit":true}]
Total Assets	-	(14.42%)	(21.82%)	(21.76%)	(14.64%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	(49.21%)	12.15%	(30.99%)	(4.20%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-404.98,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-255.03,"profit":false},{"date":"2024-12-31","value":-34.54,"profit":false}]
Non-current Liabilities	-	44.22%	29.91%	(7.37%)	(2.69%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":67.65,"profit":true},{"date":"2023-12-31","value":-16.67,"profit":false},{"date":"2024-12-31","value":-6.09,"profit":false}]
Total Liabilities	-	(15.24%)	23.14%	(15.57%)	(3.12%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-65.85,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-67.31,"profit":false},{"date":"2024-12-31","value":-13.48,"profit":false}]

Total Shareholders' equity
Common Stock	-	1.43%	1.41%	17.36%	25.44%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":5.61,"profit":true},{"date":"2022-12-31","value":5.54,"profit":true},{"date":"2023-12-31","value":68.23,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	-	38.40%	38.05%	26.50%	16.49%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.09,"profit":true},{"date":"2023-12-31","value":69.01,"profit":true},{"date":"2024-12-31","value":42.94,"profit":true}]
Other Stockholders' Equity	-	5.60%	4.91%	8.56%	8.03%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":65.42,"profit":true},{"date":"2022-12-31","value":57.36,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":93.81,"profit":true}]
Total Shareholders' equity	-	(14.30%)	(27.92%)	(23.19%)	(17.58%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Total Liabilities & Shareholders Equity	-	(14.42%)	(21.82%)	(21.76%)	(14.64%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	304.42M	303.39M	291.58M	282.65M	260.72M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":99.66,"profit":true},{"date":"2025-03-31","value":95.78,"profit":true},{"date":"2025-06-30","value":92.85,"profit":true},{"date":"2025-09-30","value":85.65,"profit":true}]
Non-current Assets	284.70M	245.32M	216.41M	187.94M	179.05M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":86.17,"profit":true},{"date":"2025-03-31","value":76.01,"profit":true},{"date":"2025-06-30","value":66.01,"profit":true},{"date":"2025-09-30","value":62.89,"profit":true}]
Total Assets	589.12M	548.71M	507.98M	470.59M	439.77M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":93.14,"profit":true},{"date":"2025-03-31","value":86.23,"profit":true},{"date":"2025-06-30","value":79.88,"profit":true},{"date":"2025-09-30","value":74.65,"profit":true}]

Total Liabilities
Current Liabilities	32.57M	35.52M	30.02M	31.68M	31.83M	[{"date":"2024-09-30","value":91.69,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":84.51,"profit":true},{"date":"2025-06-30","value":89.17,"profit":true},{"date":"2025-09-30","value":89.61,"profit":true}]
Non-current Liabilities	92.80M	91.01M	92.57M	94.36M	92.61M	[{"date":"2024-09-30","value":98.35,"profit":true},{"date":"2024-12-31","value":96.45,"profit":true},{"date":"2025-03-31","value":98.1,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":98.15,"profit":true}]
Total Liabilities	125.37M	126.53M	122.59M	126.03M	124.44M	[{"date":"2024-09-30","value":99.08,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":96.88,"profit":true},{"date":"2025-06-30","value":99.61,"profit":true},{"date":"2025-09-30","value":98.35,"profit":true}]

Total Shareholders' equity
Common Stock	210.00K	212.00K	219.00K	220.00K	223.00K	[{"date":"2024-09-30","value":94.17,"profit":true},{"date":"2024-12-31","value":95.07,"profit":true},{"date":"2025-03-31","value":98.21,"profit":true},{"date":"2025-06-30","value":98.65,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(1.76B)	(1.82B)	(1.88B)	(1.93B)	(1.97B)	[{"date":"2024-09-30","value":-175988400000,"profit":false},{"date":"2024-12-31","value":-181982300000,"profit":false},{"date":"2025-03-31","value":-187955600000,"profit":false},{"date":"2025-06-30","value":-193049900000,"profit":false},{"date":"2025-09-30","value":-197189900000,"profit":false}]
Other Stockholders' Equity	2.22B	2.24B	2.26B	2.27B	2.29B	[{"date":"2024-09-30","value":97.22,"profit":true},{"date":"2024-12-31","value":98.04,"profit":true},{"date":"2025-03-31","value":99.03,"profit":true},{"date":"2025-06-30","value":99.48,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	463.75M	422.18M	385.39M	344.56M	315.33M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":91.04,"profit":true},{"date":"2025-03-31","value":83.1,"profit":true},{"date":"2025-06-30","value":74.3,"profit":true},{"date":"2025-09-30","value":68,"profit":true}]

Total Liabilities & Shareholders Equity	589.12M	548.71M	507.98M	470.59M	439.77M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":93.14,"profit":true},{"date":"2025-03-31","value":86.23,"profit":true},{"date":"2025-06-30","value":79.88,"profit":true},{"date":"2025-09-30","value":74.65,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	(0.34%)	(3.89%)	(3.06%)	(7.76%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Non-current Assets	-	(13.83%)	(11.79%)	(13.15%)	(4.73%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Total Assets	-	(6.86%)	(7.42%)	(7.36%)	(6.55%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	9.06%	(15.49%)	5.51%	0.50%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-170.86,"profit":false},{"date":"2025-06-30","value":60.75,"profit":true},{"date":"2025-09-30","value":5.5,"profit":true}]
Non-current Liabilities	-	(1.93%)	1.71%	1.93%	(1.85%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-99.92,"profit":false},{"date":"2025-03-31","value":88.59,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-95.8,"profit":false}]
Total Liabilities	-	0.92%	(3.12%)	2.81%	(1.26%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":32.92,"profit":true},{"date":"2025-03-31","value":-110.93,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-44.92,"profit":false}]

Total Shareholders' equity
Common Stock	-	0.95%	3.30%	0.46%	1.36%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":28.84,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":13.83,"profit":true},{"date":"2025-09-30","value":41.3,"profit":true}]
Retained Earnings	-	3.41%	3.28%	2.71%	2.14%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":96.37,"profit":true},{"date":"2025-06-30","value":79.58,"profit":true},{"date":"2025-09-30","value":62.97,"profit":true}]
Other Stockholders' Equity	-	0.84%	1.02%	0.45%	0.52%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":82.29,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":44.26,"profit":true},{"date":"2025-09-30","value":51.35,"profit":true}]
Total Shareholders' equity	-	(8.96%)	(8.71%)	(10.59%)	(8.48%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Total Liabilities & Shareholders Equity	-	(6.86%)	(7.42%)	(7.36%)	(6.55%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	(115.09M)	(184.81M)	(220.52M)	(237.73M)	(200.30M)	[{"date":"2020-12-31","value":-11509300000,"profit":false},{"date":"2021-12-31","value":-18481200000,"profit":false},{"date":"2022-12-31","value":-22051900000,"profit":false},{"date":"2023-12-31","value":-23773300000,"profit":false},{"date":"2024-12-31","value":-20030000000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(505.12M)	163.66M	106.16M	163.29M	75.69M	[{"date":"2020-12-31","value":-308.65,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":64.87,"profit":true},{"date":"2023-12-31","value":99.78,"profit":true},{"date":"2024-12-31","value":46.25,"profit":true}]

Financing Activities
Net Financing Cash Flow	633.59M	11.96M	2.95M	95.69M	116.67M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":1.89,"profit":true},{"date":"2022-12-31","value":0.47,"profit":true},{"date":"2023-12-31","value":15.1,"profit":true},{"date":"2024-12-31","value":18.41,"profit":true}]

Net Change in Cash	13.38M	(9.19M)	(111.41M)	21.25M	(7.94M)	[{"date":"2020-12-31","value":62.94,"profit":true},{"date":"2021-12-31","value":-43.26,"profit":false},{"date":"2022-12-31","value":-524.26,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-37.35,"profit":false}]

Free Cash Flow
Free Cash Flow	(181.05M)	(206.26M)	(225.71M)	(239.25M)	(200.99M)	[{"date":"2020-12-31","value":-18105100000,"profit":false},{"date":"2021-12-31","value":-20625800000,"profit":false},{"date":"2022-12-31","value":-22571000000,"profit":false},{"date":"2023-12-31","value":-23924900000,"profit":false},{"date":"2024-12-31","value":-20099400000,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	60.58%	19.32%	7.81%	(15.75%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":31.89,"profit":true},{"date":"2023-12-31","value":12.89,"profit":true},{"date":"2024-12-31","value":-25.99,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(132.40%)	(35.13%)	53.82%	(53.65%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-246.02,"profit":false},{"date":"2022-12-31","value":-65.28,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-99.69,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(98.11%)	(75.34%)	3143.90%	21.92%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-3.12,"profit":false},{"date":"2022-12-31","value":-2.4,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":0.7,"profit":true}]

Net Change in Cash	-	(168.74%)	1111.77%	(119.07%)	(137.35%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-15.18,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-10.71,"profit":false},{"date":"2024-12-31","value":-12.35,"profit":false}]

Free Cash Flow
Free Cash Flow	-	13.92%	9.43%	6.00%	(15.99%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":67.74,"profit":true},{"date":"2023-12-31","value":43.08,"profit":true},{"date":"2024-12-31","value":-114.85,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(44.12M)	(36.70M)	(52.93M)	(39.03M)	(29.69M)	[{"date":"2024-09-30","value":-4411500000,"profit":false},{"date":"2024-12-31","value":-3669800000,"profit":false},{"date":"2025-03-31","value":-5292900000,"profit":false},{"date":"2025-06-30","value":-3903000000,"profit":false},{"date":"2025-09-30","value":-2968800000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(75.99M)	54.93M	6.18M	43.84M	11.94M	[{"date":"2024-09-30","value":-138.33,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":11.24,"profit":true},{"date":"2025-06-30","value":79.8,"profit":true},{"date":"2025-09-30","value":21.73,"profit":true}]

Financing Activities
Net Financing Cash Flow	679.00K	5.74M	13.99M	5.07M	3.24M	[{"date":"2024-09-30","value":4.85,"profit":true},{"date":"2024-12-31","value":41.05,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":36.25,"profit":true},{"date":"2025-09-30","value":23.13,"profit":true}]

Net Change in Cash	(119.43M)	23.98M	(32.76M)	9.88M	(14.52M)	[{"date":"2024-09-30","value":-498.05,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-136.63,"profit":false},{"date":"2025-06-30","value":41.19,"profit":true},{"date":"2025-09-30","value":-60.54,"profit":false}]

Free Cash Flow
Free Cash Flow	(44.54M)	(36.95M)	(53.03M)	(39.07M)	(29.93M)	[{"date":"2024-09-30","value":-4454400000,"profit":false},{"date":"2024-12-31","value":-3695500000,"profit":false},{"date":"2025-03-31","value":-5302800000,"profit":false},{"date":"2025-06-30","value":-3907400000,"profit":false},{"date":"2025-09-30","value":-2993100000,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	(16.81%)	44.23%	(26.26%)	(23.94%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-38.01,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-59.37,"profit":false},{"date":"2025-09-30","value":-54.12,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(172.29%)	(88.76%)	609.76%	(72.77%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-28.26,"profit":false},{"date":"2025-03-31","value":-14.56,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-11.93,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	745.80%	143.60%	(63.75%)	(36.20%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":19.25,"profit":true},{"date":"2025-06-30","value":-8.55,"profit":false},{"date":"2025-09-30","value":-4.85,"profit":false}]

Net Change in Cash	-	(120.08%)	(236.63%)	(130.15%)	(246.98%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(17.04%)	43.49%	(26.31%)	(23.40%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-39.17,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-60.5,"profit":false},{"date":"2025-09-30","value":-53.8,"profit":false}]

Allogene Therapeutics Inc Ratios

Allogene Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	ALLO
Cash Ratio	7.92
Current Ratio	8.19

Allogene Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	ALLO
ROA (LTM)	-27.34%
ROE (LTM)	-54.43%

Allogene Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	ALLO
Debt Ratio Lower is generally better. Negative is bad.	0.28
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.72

Allogene Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	ALLO
Trailing PE	NM
Forward PE	NM
P/S (TTM)	11631.14
P/B	1.16
Price/FCF	NM
EV/R	3859.62
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Allogene Therapeutics Inc share price today?

Allogene Therapeutics Inc (ALLO) share price today is $1.8

Can Indians buy Allogene Therapeutics Inc shares?

Yes, Indians can buy shares of Allogene Therapeutics Inc (ALLO) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ALLO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Allogene Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Allogene Therapeutics Inc (ALLO) via the Vested app. You can start investing in Allogene Therapeutics Inc (ALLO) with a minimum investment of $1.

How to invest in Allogene Therapeutics Inc shares from India?

You can invest in shares of Allogene Therapeutics Inc (ALLO) via Vested in three simple steps:

Click on Sign Up or Invest in ALLO stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Allogene Therapeutics Inc shares

What is Allogene Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Allogene Therapeutics Inc (ALLO) is $3.78. The 52-week low price of Allogene Therapeutics Inc (ALLO) is $0.86.

What is Allogene Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Allogene Therapeutics Inc (ALLO) is

What is Allogene Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Allogene Therapeutics Inc (ALLO) is 1.16

What is Allogene Therapeutics Inc dividend yield?

The dividend yield of Allogene Therapeutics Inc (ALLO) is 0.00%

What is the Market Cap of Allogene Therapeutics Inc?

The market capitalization of Allogene Therapeutics Inc (ALLO) is $364.06M

What is Allogene Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of Allogene Therapeutics Inc is ALLO

How Can Investors Use Allogene Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Allogene Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Allogene Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Allogene Therapeutics Inc shares for Indian investors?

When investing in Allogene Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Allogene Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Allogene Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Allogene Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Allogene Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Allogene Therapeutics Inc Share Price

Allogene Therapeutics Inc Analyst Forecast

Allogene Therapeutics Inc Share Price Chart

Allogene Therapeutics Inc Key Stock Metrics

About Allogene Therapeutics Inc, Common Stock

Allogene Therapeutics Inc Stock Returns

Allogene Therapeutics Inc Financials

Allogene Therapeutics Inc Ratios

Allogene Therapeutics Inc Liquidity Ratios

Allogene Therapeutics Inc Asset Efficiency Ratios

Allogene Therapeutics Inc Liability Ratios

Allogene Therapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Allogene Therapeutics Inc Share Price

Allogene Therapeutics Inc Analyst Forecast

Allogene Therapeutics Inc Share Price Chart

Allogene Therapeutics Inc Key Stock Metrics

About Allogene Therapeutics Inc, Common Stock

Allogene Therapeutics Inc Stock Returns

Allogene Therapeutics Inc Financials

Allogene Therapeutics Inc Ratios

Allogene Therapeutics Inc Liquidity Ratios

Allogene Therapeutics Inc Asset Efficiency Ratios

Allogene Therapeutics Inc Liability Ratios

Allogene Therapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²